By Katherine Hamilton
Zynex is cutting 15% of its workforce after health insurance company Tricare temporarily suspended payments.
The medical device maker said Tuesday it plans to cut jobs because Tricare has suspended payments while it reviews prior claims, and it is unclear when that will be resolved.
Tricare represents about 20% to 25% of Zynex's annual revenue. Zynex plans to meet with Tricare in April and said it believes it has good evidence to get payments reinstated.
Fourth-quarter revenue was lower than expected due to Tricare's suspension, falling to $46 million, from $47.3 million in the prior-year period.
The job cuts are expected to primarily affect corporate employees, Zynex said. The cuts, along with other cost reductions, are set to save about $35 million annually.
Zynex reduced its headcount previously, which cut sales and marketing expenses in the fourth quarter, it said.
Write to Katherine Hamilton at katherine.hamilton@wsj.com
(END) Dow Jones Newswires
March 11, 2025 16:53 ET (20:53 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。